Iron excretion in thalassemia children treated with deferoxamin methansulfonat: intravenous drip compared to the subcutaneous routes.
The iron excretion in the three beta-Thal/Hb E patients were determined comparing the effect of DF given by subcutaneous push, subcutaneous drip and intravenous drip. The subcutaneous drip or intravenous drip increased urine iron excretion by 5.6-11.2 times whereas the subcutaneous push, 3.5-5.3 times only. It is recommended that for countries where the infusion machine is very expensive the DF should be given by intravenous drip or the modified, simple and inexpensive equipment for subcutaneous drip.
Hathirat
P
P
Areekul
S
S
Isarangkura
P
P
Chantachum
Y
Y
D000293:Adolescent; D002648:Child; D003676:Deferoxamine / Q000008:administration & dosage*; D006801:Humans; D007260:Infusion Pumps; D007262:Infusions, Intravenous; D007501:Iron / Q000652:urine*; D008297:Male; D013789:Thalassemia / Q000188:drug therapy / Q000652:urine*
D007501:Iron; D003676:Deferoxamine